rPogyny announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis, a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists, and a Menopause Society Certified Practitioner, and Columbia University’s Dr. Whitney Booker, a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine, to its Medical Advisory Board.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny’s Strong Results Overshadowed by ART Cycle Decline and Core Business Uncertainty
- Progyny price target lowered to $21 from $23 at Canaccord
- Progyny’s Cautious Outlook: Hold Rating Amid Market Uncertainty and Conservative Guidance
- Progyny, Inc. Earnings Call Highlights Growth and Challenges
- Progyny, Inc. Reports Strong Q1 2025 Results